T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice

Cell

Volumn 134, Issue 4, 2008, Pages 577-586

  Kumar, Priti ^a   Ban, Hong Seok ^b   Kim, Sang Soo ^a   Wu, Haoquan ^a   Pearson, Todd ^c   Greiner, Dale L ^c   Laouar, Amale ^a   Yao, Jiahong ^a   Haridas, Viraga ^a   Habiro, Katsuyoshi ^a   Yang, Yong Guang ^a   Jeong, Ji Hoon ^d   Lee, Kuen Yong ^b   Kim, Yong Hee ^b   Kim, Sung Wan ^d   Peipp, Matthias ^e   Fey, Georg H ^f   Manjunath, N ^a   Shultz, Leonard D ^g   Lee, Sang Kyung ^b   Shankar, Premlata ^a   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b Hanyang University   (South Korea)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e UNIVERSITY OF KIEL   (Germany)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g JACKSON LABORATORY   (United States)

Author keywords

CELLIMMUNO; HUMDISEASE

Indexed keywords

ARGININE DERIVATIVE; SCFVCD7 9R; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL LOSS; CONTROLLED STUDY; FEASIBILITY STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; MOUSE; NEWBORN; NONHUMAN; NONOBESE DIABETIC MOUSE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

EID: 49549117077     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2008.06.034     Document Type: Article

References (47)

1. Anderson J., Li M.J., Palmer B., Remling L., Li S., Yam P., Yee J.K., Rossi J., Zaia J., and Akkina R. Safety and efficacy of a lentiviral vector containing three anti-HIV genes-CCR5 ribozyme, tat-rev siRNA, and TAR decoy-in SCID-hu mouse-derived T cells. Mol. Ther. 15 (2007) 1182-1188
2. Banerjea A., Li M.-J., Bauer G., Remling L., Lee N.-S., Rossi J., and Akkina R. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol. Ther. 8 (2003) 62-71
3. Berges B.K., Wheat W., Palmer B., Connick E., and Akkina R. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gammac-/- (RAG-hu) mouse model. Retrovirology 3 (2006) 76
4. Berges B.K., Akkina S.R., Folkvord J.M., Connick E., and Akkina R. Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2(-/-)gammac(-/-) (RAG-hu) mice. Virology 373 (2008) 342-351
5. Bonilla F.A., Kokron C.M., Swinton P., and Geha R.S. Targeted gene disruption of murine CD7. Int. Immunol. 9 (1997) 1875-1883
6. Brake O.T., Hooft K.T., Liu Y.P., Centlivre M., Jasmijn von Eije K., and Berkhout B. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol. Ther. 16 (2008) 557-564
7. Bremer E., Samplonius D.F., Peipp M., van Genne L., Kroesen B.-J., Fey G.H., Gramatzki M., de Leij L.F.M.H., and Helfrich W. Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7. Cancer Res. 65 (2005) 3380-3388
8. Caron G., Duluc D., Fremaux I., Jeannin P., David C., Gascan H., and Delneste Y. Direct stimulation of human T cells via TLR5 and TLR7/8: Flagellin and R-848 up-regulate proliferation and IFN-{gamma} production by memory CD4+ T cells. J. Immunol. 175 (2005) 1551-1557
9. Chun T.-W., Stuyver L., Mizell S.B., Ehler L.A., Mican J.A.M., Baseler M., Lloyd A.L., Nowak M.A., and Fauci A.S. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94 (1997) 13193-13197
10. Fais S., Lapenta C., Santini S.M., Spada M., Parlato S., Logozzi M., Rizza P., and Belardelli F. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection. J. Virol. 73 (1999) 6453-6459
11. Finzi D., Blankson J., Siliciano J.D., Margolick J.B., Chadwick K., Pierson T., Smith K., Lisziewicz J., Lori F., Flexner C., et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5 (1999) 512-517
12. Frankel A.E., Laver J.H., Willingham M.C., Burns L.J., Kersey J.H., and Vallera D.A. Therapy of patients with T-cell lymphomas and leukemias using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin. Leuk. Lymphoma 26 (1997) 287-298
13. Goffinet C., and Keppler O.T. Efficient nonviral gene delivery into primary lymphocytes from rats and mice. FASEB J. 20 (2006) 500-502
14. Gorantla S., Sneller H., Walters L., Sharp J.G., Pirruccello S.J., West J.T., Wood C., Dewhurst S., Gendelman H.E., and Poluektova L. Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-{gamma}c-/- mice. J. Virol. 81 (2007) 2700-2712
15. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., and Kay M.A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441 (2006) 537-541
16. Hamamoto K., Kida Y., Zhang Y., Shimizu T., and Kuwano K. Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol. Immunol. 46 (2002) 741-749
17. Hogrefe R.I., Lebedev A.V., Zon G., Pirollo K.F., Rait A., Zhou Q., Yu W., and Chang E.H. Chemically modified short interfering hybrids (siHYBRIDS): Nanoimmunoliposome delivery in vitro and in vivo for RNAi of HER-2. Nucleosides Nucleotides Nucleic Acids 25 (2006) 889-907
18. Ishikawa F., Yasukawa M., Lyons B., Yoshida S., Miyamoto T., Yoshimoto G., Watanabe T., Akashi K., Shultz L.D., and Harada M. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chainnull mice. Blood 106 (2005) 1565-1573
19. John M., Constien R., Akinc A., Goldberg M., Moon Y.-A., Spranger M., Hadwiger P., Soutschek J., Vornlocher H.-P., Manoharan M., et al. Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway. Nature 449 (2007) 745-747
20. Kim W.J., Christensen L.V., Jo S., Yockman J.W., Jeong J.H., Kim Y.-H., and Kim S.W. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol. Ther. 14 (2006) 343-350
21. Kumar P., Wu H., McBride J.L., Jung K.-E., Hee Kim M., Davidson B.L., Kyung Lee S., Shankar P., and Manjunath N. Transvascular delivery of small interfering RNA to the central nervous system. Nature 448 (2007) 39-43
22. Lazarovits A.I., Rochon J., Banks L., Hollomby D.J., Muirhead N., Jevnikar A.M., White M.J., Amlot P.L., Beauregard-Zollinger L., and Stiller C.R. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection. J. Immunol. 150 (1993) 5163-5174
23. Lee S.-K., Dykxhoorn D.M., Kumar P., Ranjbar S., Song E., Maliszewski L.E., Francois-Bongarcon V., Goldfeld A., Swamy N.M., Lieberman J., et al. Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 106 (2005) 818-826
24. Levine B.L., Humeau L.M., Boyer J., MacGregor R.-R., Rebello T., Lu X., Binder G.K., Slepushkin V., Lemiale F., Mascola J.R., et al. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. USA 103 (2006) 17372-17377
25. Lipsick J.S., and Boyle W.J. c-myb protein expression is a late event during T-lymphocyte activation. Mol. Cell. Biol. 7 (1987) 3358-3360
26. Manjunath N., Kumar P., Lee S.K., and Shankar P. Interfering antiviral immunity: Application, subversion, hope?. Trends Immunol. 27 (2006) 328-335
27. Marasco W.A., and Sui J. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat. Biotechnol. 25 (2007) 1421-1434
28. Nakata H., Maeda K., Miyakawa T., Shibayama S., Matsuo M., Takaoka Y., Ito M., Koyanagi Y., and Mitsuya H. Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor {gamma}-chain-knocked-out AIDS mouse model. J. Virol. 79 (2005) 2087-2096
29. Novina C.D., Murray M.F., Dykxhoorn D.M., Beresford P.J., Riess J., Lee S.-K., Collman R.G., Lieberman J., Shankar P., and Sharp P.A. siRNA-directed inhibition of HIV-1 infection. Nat. Med. 8 (2002) 681-686
30. Peer D., Zhu P., Carman C.V., Lieberman J., and Shimaoka M. Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc. Natl. Acad. Sci. USA 104 (2007) 4095-4100
31. Peipp M., Kupers H., Saul D., Schlierf B., Greil J., Zunino S.J., Gramatzki M., and Fey G.H. A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells. Cancer Res. 62 (2002) 2848-2855
32. Rossi J.J., June C.H., and Kohn D.B. Genetic therapies against HIV. Nat. Biotechnol. 25 (2007) 1444-1454
33. Scherer L., Rossi J.J., and Weinberg M.S. Progress and prospects: RNA-based therapies for treatment of HIV infection. Gene Ther. 14 (2007) 1057-1064
34. Shacklett B.L. Can the new humanized mouse model give HIV research a boost. PLoS Med. 5 (2008) e13
35. Shankar P., Manjunath N., and Lieberman J. The prospect of silencing disease using RNA interference. JAMA 293 (2005) 1367-1373
36. Song E., Lee S.-K., Dykxhoorn D.M., Novina C., Zhang D., Crawford K., Cerny J., Sharp P.A., Lieberman J., Manjunath N., et al. Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J. Virol. 77 (2003) 7174-7181
37. Song E., Lee S.K., Wang J., Ince N., Ouyang N., Min J., Chen J., Shankar P., and Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9 (2003) 347-351
38. Song E., Zhu P., Lee S.-K., Chowdhury D., Kussman S., Dykxhoorn D.M., Feng Y., Palliser D., Weiner D.B., Shankar P., et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 23 (2005) 709-717
39. Surabhi R.M., and Gaynor R.B. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication. J. Virol. 76 (2002) 12963-12973
40. Svoboda P. Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr. Opin. Mol. Ther. 9 (2007) 248-257
41. ter Brake O., Konstantinova P., Ceylan M., and Berkhout B. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol. Ther. 14 (2006) 883-892
42. von Eije K.J., ter Brake O., and Berkhout B. HIV-1 escape is restricted when conserved genome sequences are targeted by RNA interference. J. Virol. 82 (2007) 2895-2903
43. Wan L., Zeng L., Chen L., Huang Q., Li S., Lu Y., Li Y., Cheng J., and Lu X. Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin. Protein Expr. Purif. 48 (2006) 307-313
44. Watanabe S., Ohta S., Yajima M., Terashima K., Ito M., Mugishima H., Fujiwara S., Shimizu K., Honda M., Shimizu N., et al. Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J. Virol. 81 (2007) 13259-13264
45. Wu H., Neilson J.R., Kumar P., Manocha M., Shankar P., Sharp P.A., and Manjunath N. miRNA profiling of naïve, effector and memory CD8 T cells. PLoS ONE 2 (2007) e1020
46. Xiao C., Calado D.P., Galler G., Thai T.H., Patterson H.C., Wang J., Rajewsky N., Bender T.P., and Rajewsky K. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131 (2007) 146-159
47. Zeng F., Peritz T., Kannanayakal T.J., Kilk K., Eiriksdottir E., Langel U., and Eberwine J. A protocol for PAIR: PNA-assisted identification of RNA binding proteins in living cells. Nat. Protoc. 1 (2006) 920-927